Skip to main content

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP); Diagnosis: Immunopathogenesis and Advances of Immunotherapy

Marinos Dalakas, MD

Dr. Dalakas is Professor of Neurology and Director of the Neuromuscular Division at Thomas Jefferson University School of Medicine and he is the Chief of the Neuroimmunology Laboratory and Professor of Neurology at the Athens University Medical School. Dr. Dalakas has published over 200 peer-reviewed articles, reviews and editorials as well as many textbook chapters. He acts as an active member of the Editorial Boards of many of the leading medical journals as well and is an active professor and worldwide lecturer.
Start Presentation

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP); Diagnosis: lmmunopathogenesis and Advances in lmmunotherapy

Course Description:
This course reviews clinical criteria of CIDP, distingushing it from other diseases & the immunological mechanisms responsible for the pathogenisis of CIDP.

Target Audience: 
This activity is intended for general neurologists, neuromuscular specialists, neurology nurse practitioners and physician assistants.

Learning Objectives:
  • Highlight the evolved clinical and electrodiagnostic criteria of CIDP and discuss how best the practicing neurologist can distinguish CIDP from disease mimics
  • Present the immunological mechanisms responsible for the pathogenesis of CIDP and present the significance of the newly identified nodal antibodies
  • Provide practical guidelines on immune therapies, based on controlled trials, and discuss ongoing progress on future target-specific therapies
To receive a Continuing Medical Education certificate, attend the presentation, complete the post-test, and the post-presentation evaluation.